How have CIZ shares performed in 2023?

Cizzle Biotechnology's stock was trading at GBX 1.45 at the start of the year. Since then, CIZ stock has increased by 64.5% and is now trading at GBX 2.39. View the best growth stocks for 2023 here .

How often does Cizzle Biotechnology pay dividends? What is the dividend yield for Cizzle Biotechnology?

Cizzle Biotechnology announced a monthly dividend on Tuesday, May 9th. Stockholders of record on Thursday, May 11th will be given a dividend of GBX 0.09 per share on Friday, May 12th. This represents a $1.08 dividend on an annualized basis and a yield of 45.28%. The ex-dividend date of this dividend is Wednesday, May 10th. Read our dividend analysis for CIZ .

What does CIZ invest in?

Cizzle Biotechnology is a equity fund issued by Victory Capital Management. CIZ focuses on large cap investments and follows the Nasdaq Victory?International 500 Long/Cash Volatility Weighted Index. The fund's investments total to approximately $48.98 million assets under management.

What stocks does Cizzle Biotechnology hold?

CIZ invests in 505 holdings. Some of the stocks in their portfolio include BCE (BCE) , (GWO) (GWO) , Metro, Inc. (TSE) (MRU) , WisdomTree International LargeCap Dividend Fund (DOL) , Fortis (FTS) , Hyatt Hotels (H) , Powered Brands (POW) , Royal Bank of Canada (RY) , Sun Life Financial (SLF) and Loews (L) .

What is the management fee for Cizzle Biotechnology?

Cizzle Biotechnology's management fee is 0.40% and has other expenses of 0.25%. However, CIZ has a fee waiver of -0.20% to reimburse the expenses. The net expense ratio for CIZ is 0.46%.

How do I buy shares of Cizzle Biotechnology?

Shares of CIZ stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

Cizzle Biotechnology Share Price, News & Analysis (LON:CIZ)

GBX 2.38

+0.01 (+0.42%)

(As of 02:19 PM ET)

Today's Range: 2.36
▼
2.56
50-Day Range: 1.71
▼
2.50
52-Week Range: 1.36
▼
4.84

Volume: 2.08 million shs
Average Volume: 3.51 million shs
Market Capitalization: £8.68 million

Assets Under Management: £48.98 million
Dividend Yield: 3.31%
Net Expense Ratio: 0.46%

Stock Analysis Chart Dividend Headlines Holdings Ownership Ratings

About Cizzle Biotechnology (LON:CIZ)

Cizzle Biotechnology Holdings Plc engages in development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.

CIZ Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CIZ ETF News Headlines

August 15, 2023 | lse.co.uk

Murphy Canyon to hold meeting on planned buy of interest in AZD1656

August 10, 2023 | lse.co.uk

TRADING UPDATES: Aterian granted 10 exploration licences in Morocco

December 6, 2023 | Financial Alphas (Ad)

Lithium Discovery So BIG You Can't Miss it, Even From Space

With the green energy transition well underway, lithium demand is rapidly outpacing projected supply. While companies frantically search for new sources of this critical metal, one small company is sitting on a massive claim in North America - So big in fact that it can clearly be seen from space!

July 18, 2023 | bizjournals.com

Philadelphia Biotech News

July 16, 2023 | investing.com

Cizzle Biotechnology Holdings PLC (CIZ)

June 12, 2023 | lse.co.uk

Cizzle subscription raises GBP350,000 to fund development pipeline

June 12, 2023 | marketwatch.com

Cizzle Biotechnology Raises GBP350,000 via Subscription

May 23, 2023 | finance.yahoo.com

Institutional investors own a significant stake of 50% in Cizzle Biotechnology Holdings Plc (LON:CIZ)

December 6, 2023 | Financial Alphas (Ad)

Lithium Discovery So BIG You Can't Miss it, Even From Space

April 22, 2023 | investing.com

EFA ETF Volatility (VXEFA)

See More Headlines

Receive CIZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cizzle Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer: Victory Capital Management
Fund Name: VictoryShares Developed Enhanced Volatility Wtd ETF
Tax Classification: Regulated Investment Company
Stock Exchange: LON
Current Symbol: LON:CIZ
Inception Date: 9/30/2014
Fund Manager: Mannik Dhillon, Stephen Hammers
Web: www.cizzlebiotechnology.com
Phone: N/A

Fund Focus

Asset Class: Equity
Benchmark: Nasdaq Victory?International 500 Long/Cash Volatility Weighted Index
Category: Size and Style
Focus: Large Cap
Development Level: Developed Markets
Region: Global Ex-U.S.
Number of Holdings: 505

Fund Statistics

Assets Under Management: $48.98 million
Average Daily Volume: $9,243.20
Discount/Premium: 0.17%

Administrator, Advisor and Custodian

Administrator: Victory Capital Management Inc.
Advisor: Victory Capital Management Inc.
Custodian: Citibank, N.A.
Distributor: Foreside Fund Services, LLC
Transfer Agent: Citibank, N.A.
Trustee: N/A
Lead Market Maker: RBC Capital Markets

Options

Optionable: N/A
Short Interest: 15,600 shs

Miscellaneous

Outstanding Shares: 363,840,000
Beta: 0.13
Creation Unit: 50,000
Creation Fee: $4,500.00

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Cizzle Biotechnology Expenses

Type	CIZ	Large Cap ETFs	Equity ETFs	LON ETFs	All ETFs
Management Fee	0.40%	0.56%	0.53%	0.45%	0.51%
Other Expenses	0.25%	0.30%	0.53%	0.25%	0.57%
Total Expense	0.66%	0.63%	0.69%	0.54%	0.69%
Fee Waiver	-0.20%	-0.20%	-0.54%	-0.20%	-0.58%
Net Expense	0.46%	0.60%	0.59%	0.47%	0.57%

Cizzle Biotechnology (CIZ) Holdings & Exposure

Top 10 CIZ Holdings

Federated Hermes Treasury Obl IS
Holding Weight: 75.19%
Mini Msci Eafe Fut Dec23
Holding Weight: 0.47%
Murata Manufacturing Co Ltd
Holding Weight: 0.15%
Futures Collateral - Cash
Holding Weight: 0.13%
Honda Motor Co Ltd
Holding Weight: 0.13%
Keyence Corp
Holding Weight: 0.12%
SoftBank Corp
Holding Weight: 0.12%
BCE(NYSE:BCE)
Holding Weight: 0.09%
(GWO)(NYSEARCA:GWO)
Holding Weight: 0.09%
Koninklijke KPN NV
Holding Weight: 0.09%

CIZ Sector Exposure

CIZ Industry Exposure

Full Holdings Details

Key Executives

Mr. Allan John Syms (Age 66)
Executive Chairman
Prof. Dawn Coverley (Age 57)
Founder, Chief Scientific Officer & Non-Executive Director
Mr. Nigel R. Lee (Age 61)
Finance Director & Executive Director
Mr. Morgan Williams
Head of Commercialisation for Yorkshire Cancer Research and Board Observer

CIZ ETF - Frequently Asked Questions

How have CIZ shares performed in 2023?: Cizzle Biotechnology's stock was trading at GBX 1.45 at the start of the year. Since then, CIZ stock has increased by 64.5% and is now trading at GBX 2.39.
View the best growth stocks for 2023 here.
How often does Cizzle Biotechnology pay dividends? What is the dividend yield for Cizzle Biotechnology?: Cizzle Biotechnology announced a monthly dividend on Tuesday, May 9th. Stockholders of record on Thursday, May 11th will be given a dividend of GBX 0.09 per share on Friday, May 12th. This represents a $1.08 dividend on an annualized basis and a yield of 45.28%. The ex-dividend date of this dividend is Wednesday, May 10th.
Read our dividend analysis for CIZ.
What does CIZ invest in?: Cizzle Biotechnology is a equity fund issued by Victory Capital Management. CIZ focuses on large cap investments and follows the Nasdaq Victory?International 500 Long/Cash Volatility Weighted Index. The fund's investments total to approximately $48.98 million assets under management.
What stocks does Cizzle Biotechnology hold?: CIZ invests in 505 holdings. Some of the stocks in their portfolio include BCE (BCE), (GWO) (GWO), Metro, Inc. (TSE) (MRU), WisdomTree International LargeCap Dividend Fund (DOL), Fortis (FTS), Hyatt Hotels (H), Powered Brands (POW), Royal Bank of Canada (RY), Sun Life Financial (SLF) and Loews (L).

What is the management fee for Cizzle Biotechnology?: Cizzle Biotechnology's management fee is 0.40% and has other expenses of 0.25%. However, CIZ has a fee waiver of -0.20% to reimburse the expenses. The net expense ratio for CIZ is 0.46%.
How do I buy shares of Cizzle Biotechnology?: Shares of CIZ stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:CIZ) was last updated on 12/6/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial